SANA

Sana Biotechnology, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.16

+0.02 (+0.64%)

Rating:D+

Company Profile

CEO

Steven D. Harr

IPO Date

2021-02-04

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$3.12

Prev. Close

$3.14

Day Low

$3.11

Day High

$3.24

52W Low

$2.61

52W High

$6.55

Market Cap

$0.88B

Volume

2.10M

News SentimentBullish

Articles

Avg Positive

34.0%

Avg Negative

1.2%

Avg Neutral

64.9%

News Feed

Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates

GlobeNewsWire·7/14/2021·↑ positive

Sana Biotechnology: Hypoimmune Cell Therapies

Seeking Alpha·6/30/2021·↑ positive

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates